Meeting the standard : an overview of European biobank regulation and a comparison to the current South African position
Loading...
Date
Authors
Prinsen, Larisse
Journal Title
Journal ISSN
Volume Title
Publisher
Edinburgh University Press
Abstract
Due to the fascinating new developments in biomedicine such as stem cell therapy and tissue
engineering, contemporary medicine is moving away from being a reactionary process to
being a process which focuses on the maintenance of health by being personal, predictive,
preventative and participatory.1 This means that medicine is moving away from the
traditional forms of treatment, to a point where treatment and experimentation almost merge,
and thus it is also moving away from the known forms of regulatory frameworks and
mechanisms. In fact, the proper and best method of regulating biomedicine is uncertain and
will be subject to a process of trial and error for many years. This is true on a global scale and
also on a local South African one. This regulatory process is also slowed down and delayed
to some extent while each role player, be that an authority or institution or practitioner or
researcher or even country, attempts to solve all the issues individually since this leads to a
nonconformist and confusing mass of incoherent binding and nonbinding legal and ethical
documents, guidelines and rules. This in turn hinders sharing of information, data and
ultimately knowledge and subsequent development.2 A uniform system would encourage and facilitate sharing and this would lead to collaboration and better and faster development of biomedicine.
Description
Keywords
Overview, European biobank regulation, South African position, Comparison
Sustainable Development Goals
Citation
Prinsen, L 2015, 'Meeting the standard : an overview of European biobank regulation and a comparison to the current South African position', African Journal of International and Comparative Law, vol. 23, no. 1, pp. 54-73.